Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCX4208 and Allopurinol in Gout
NCT01129648Phase 2Completed
- Sponsor
- BioCryst Pharmaceuticals, Inc.
- Start
- May 2010
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Ulodesine in gout, sponsored by BioCryst Pharmaceuticals, Inc.. Started May 2010; status: completed.
02
Drugs
Ulodesine
03
Conditions
gout
Beyond the preview
Go deeper on NCT01129648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01129648.